Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

<table>The protein mass profile between <i>m/z</i> 0 and 10000 highlighting the differentially expressed peaks in serum from healthy volunteers, patients with benign biliary disease, and BTC patients. The <i>m/z</i> 4204 peak (indicated by arrows) intensity was higher in cancer patients compared with patients with benign disease and healthy volunteers.</table>

International Journal of Proteomics

fig1

Figure 1

Figure 1: Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry 

Figure 1 | Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry 